摘要:
A solid electrolyte composite is provided comprising a NaSICON framework of the formula NaxAyBzP3−zOw wherein A is one or more metal ions, B is one or more ions having a pentavalence, and x is a number ranging from 1 to 12, y is a number ranging from 1 to 2, z is a number ranging from 0 to 3, and w is a number ranging from 4 to 12, wherein B is present or absent, and a glass material. A battery is disclosed having at least one cathode and anode and the solid electrolyte glass phase composite described above disposed between at least one of the anode and cathode. A method for making the solid electrolyte composite is set forth.
摘要:
Several attempts have been tried to improve the performance of intra-prediction in video encoding and decoding, which are targeting at pixel level parallelization. A solution for implementing an improved intra-prediction method on a parallel processing platform uses estimated predictors instead of reconstructed exact predictors. This enables faster estimation of predictors, and allows an encoder to perform intra-prediction for all blocks of at least a portion of an image simultaneously.
摘要:
Biocompatible polymeric coating compositions having nanoscale surface roughness and methods of forming such coatings are described. A polymeric biocompatible coating may be produced using a powder coating method, where one or more thermosetting polymer resins and one or more biocompatible materials are mixed and extruded, ground into microscale particles, and mixed with nanoparticles to form a dry powder mixture that may be coated onto a substrate according to a powder coating method. Alternatively, the thermosetting polymeric resin can be first extruded and ground into microscale particles, and then mixed with the biocompatible materials in particular form of nanoscale to microscale in size, and then further mixed with nanoparticles to form a dry powder mixture for coating. Bioactive materials may also be selectively added into the polymeric coating in a similar way as the biocompatible materials, either before or after the extrusion, to form a bioactive polymeric coating.
摘要:
A method of analyzing a wellbore fluid that includes treating a wellbore fluid with an emulsifying fluid, the emulsifying fluid comprising: a hydroxylated ether; an amphoteric chemotrope; and testing the treated wellbore fluid for at least one of turbidity and total suspended solids is disclosed. Methods of cleaning wellbores are also disclosed.
摘要:
Monitoring performance data associated with a content player is disclosed. Information relating to the state of a content player is obtained on a time driven basis. At least a portion of the obtained information is reported, via a communications interface, to a content distribution monitoring server.
摘要:
The present invention relates to 9-aminomethyl substituted tetracycline compounds represented by formula (I), or pharmaceutically acceptable salt, prodrug, solvate or isomer thereof, as well as a method for preparing these compounds and a pharmaceutical composition comprising the same. The present invention relates also to a use of these compounds in the preparation of a medicament for the treatment and/or prophylaxis of tetracycline drug-sensitive disease. wherein, R2a, R2b, R3, R4a, R4b, R5, R6a, R6b, R7, R8, R9a, R9b, R10, R11, R12, R13a and R13b are each independently as defined in the description.
摘要:
A modeling method, medium, and system. The modeling method may include specifying an object in a plurality of 2 dimensional (2D) images expressed from different view points, considering an edge and contents of each component of each 2D image, generating a 3 dimensional (3D) model of each specified object, and matching the generated 3D models considering relative locations of each generated 3D model. Accordingly, a realistic 3D model of an object expressed in an image can be accurately generated.
摘要:
The present invention relates to a 1,4-dihydropyridine-3,5-dicarboxylate compound of general compound (I), a process for preparing the same, a use thereof for the manufacture of a medicament for treating and/or preventing kidney injury, cardiovascular diseases and/or endocrine diseases, as well as a pharmaceutical composition and a pharmaceutical formulation containing said compounds, wherein the definitions of R1, R2, R3, R4, R5, R6, R7, R8, m, n1, n2, p and q are the same as those defined in the description.
摘要:
Certain circuit models include design parameters that reflect user choices and statistical parameters that reflect modeling uncertainty. For each performance goal (e.g., a one-sided performance goal), a closest point of failure in the statistical parameters is used to identify a statistical corner that characterizes a specified tolerance for that performance goal. Adjusting the design parameters to improve performance for these corners improves overall performance and corresponding yields.
摘要:
A method, system, and computer-readable storage medium are disclosed for determining one or more symmetries in an image comprising a plurality of pixels. A symmetry value may be automatically determined for each of the plurality of pixels. The symmetry value may indicate the strength of one or more symmetries in the image for the respective pixel. The symmetry value may be stored for each of the pixels.